AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Public ClinicalTrials.gov record NCT00547651. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AMR PH GL 2007 CL001 Phase 3 A Randomized, Open-Label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy
Study identification
- NCT ID
- NCT00547651
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Celgene
- Industry
- Enrollment
- 637 participants
Conditions and interventions
Conditions
Interventions
- Amrubicin Drug
- Topotecan Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2007
- Primary completion
- Apr 30, 2011
- Completion
- Apr 30, 2011
- Last update posted
- Nov 5, 2019
2007 – 2011
United States locations
- U.S. sites
- 61
- U.S. states
- 29
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Alabama Cancer Center | Muscle Shoals | Alabama | 35661 | — |
| Arizona Oncology Associates | Tucson | Arizona | 85704 | — |
| Little Rock Hematology Oncology Associates | Little Rock | Arkansas | 72205 | — |
| Cancer Care Associates of Fresno Medical Group, Inc. | Fresno | California | 93720 | — |
| Cedars-Sinai Outpatient Cancer Center | Los Angeles | California | 90048 | — |
| University of Colorado Health Science Centre | Aurora | Colorado | 80045 | — |
| Rocky Mountain Cancer Center - Midtown (Main) | Denver | Colorado | 80218 | — |
| Advanced Medical Specialties | Miami | Florida | 33176 | — |
| Ocala Oncology Center | Ocala | Florida | 34474 | — |
| Cancer Centers of Florida, P.A. | Ocoee | Florida | 34761 | — |
| Florida Oncology Associates | Orange Park | Florida | 32073 | — |
| Sacred Heart Medical Oncology | Pensacola | Florida | 32504 | — |
| Medical Oncology Associates of Augusta | Augusta | Georgia | 30809 | — |
| Joliet Oncology-Hematology Associates, Ltd. | Joliet | Illinois | 60435 | — |
| Cancer & Hematology Specialists of Chicago (Main) | Niles | Illinois | 60714 | — |
| Illinois Cancer Care | Peoria | Illinois | 61615 | — |
| Cancer Care at Blessing Hospital | Quincy | Illinois | 62301 | — |
| Central Indiana Cancer Centers | Indianapolis | Indiana | 46227 | — |
| Hope Center | Terre Haute | Indiana | 47802 | — |
| Kansas City Cancer Center (Main) | Overland Park | Kansas | 66210 | — |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | — |
| Jayne Gurtler MD, Laura Brizn MD, Angelo Russo MD, and Janet Burroff MD, APMC | Metairie | Louisiana | 70006 | — |
| Tulane University Health Sciences Center | New Orleans | Louisiana | 70112 | — |
| Maine Center for Cancer Medicine and Blood Disorders | Scarborough | Maine | 04074 | — |
| Sinai Hospital of Baltimore, Inc. | Baltimore | Maryland | 21215 | — |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| Alliance Hematology Oncology, P.A. (Main) | Westminster | Maryland | 21157 | — |
| Kalamazoo Hematology and Oncology | Kalamazoo | Michigan | 49048 | — |
| Michigan Hematology & Oncology Institute | Southgate | Michigan | 48195 | — |
| University of Minnesota Medical Center, Cancer Center | Minneapolis | Minnesota | 55455 | — |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | — |
| St. Joseph Oncology, Inc. | Saint Joseph | Missouri | 64507 | — |
| Comprehensive Care Centers of Nevada (Main) | Las Vegas | Nevada | 89169 | — |
| New York Oncology Hematology, P.C. | Latham | New York | 12110-0610 | — |
| SUNY Upstate Medical University - Regional Oncology Center | Syracuse | New York | 13210 | — |
| Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | — |
| Regional Cancer Care | Durham | North Carolina | 27704 | — |
| Cancer Centers of North Carolina (Main) | Raleigh | North Carolina | 27607 | — |
| Piedmont Hematology Oncology Associates | Winston-Salem | North Carolina | 27103 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Greater Dayton Cancer Center (Main) | Kettering | Ohio | 45409 | — |
| Cancer Care Associates | Oklahoma City | Oklahoma | 73112 | — |
| Cancer Care Associates | Tulsa | Oklahoma | 74136 | — |
| Willamette Valley Cancer Center (Main) | Eugene | Oregon | 97401-8122 | — |
| Medical Oncology Associates | Kingston | Pennsylvania | 18704 | — |
| Thomas Jefferson Memorial Hospital | Philadelphia | Pennsylvania | 19107 | — |
| UPMC Cancer Pavilion | Pittsburgh | Pennsylvania | 15232 | — |
| Cancer Centers of the Carolinas (Main) | Greenville | South Carolina | 29615 | — |
| The Sarah Cannon Research Institute/TN Oncology | Nashville | Tennessee | 37203 | — |
| Texas Oncology, P.A. | Amarillo | Texas | 79106 | — |
| Coastal Bend Cancer Center | Corpus Christi | Texas | 78463 | — |
| Texas Cancer Center at Medical City (Main) | Dallas | Texas | 75230-2510 | — |
| Texas Oncology, P.A. (Main) | Dallas | Texas | 75246 | — |
| West Texas Cancer Center-Texas Oncology | Odessa | Texas | 79761 | — |
| Texas Oncology, P.A. | Webster | Texas | 77598-4420 | — |
| Texoma Cancer Center | Wichita Falls | Texas | 76310 | — |
| Fairfax Northern Virginia Hematology/Oncology | Fairfax | Virginia | 22031 | — |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | — |
| Blue Ridge Cancer Care | Roanoke | Virginia | 24019 | — |
| Northwest Cancer Specialists - Vancouver (Main) | Vancouver | Washington | 98684 | — |
| Marshfield Clinic | Marshfield | Wisconsin | 54449 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 79 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00547651, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2019 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00547651 live on ClinicalTrials.gov.